Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy

Abstract

The association of obesity at diagnosis with prostate cancer progression is uncertain. This study aimed to examine the relationship between body mass index (BMI; 18.5–<25, 25–<30, 30–<35, ≥35 kg/m2) and prognostic risk at diagnosis, compare the concordance between prognostic risk assessed at diagnostic biopsy versus pathologic risk assessed at surgery across BMI categories, and investigate the association between obesity and prostate cancer recurrence and all-cause death.

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2019
Source ID
10.1158/1055-9965.epi-19-0488

Entities

People

  • Crystal S Langlais
  • Erin Lynn Van Blarigan
  • Janet E Cowan
  • Jeanette Broering
  • John Neuhaus
  • June M. Chan
  • Matthew R Cooperberg
  • Peter Carroll
  • Stacey A Kenfield

Organizations

  • National Cancer Institute
  • National Institute on Aging
  • United States Department of Defense
  • University of California, San Francisco

Tags

Fields of Study

  • Medicine

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Prostate Cancer Biology.